<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:57:51Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6380471" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6380471</identifier>
        <datestamp>2019-02-19</datestamp>
        <setSpec>elsevierwt</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Clin Nutr</journal-id>
              <journal-id journal-id-type="iso-abbrev">Clin Nutr</journal-id>
              <journal-title-group>
                <journal-title>Clinical Nutrition (Edinburgh, Scotland)</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0261-5614</issn>
              <issn pub-type="epub">1532-1983</issn>
              <publisher>
                <publisher-name>Elsevier</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6380471</article-id>
              <article-id pub-id-type="pmcid">PMC6380471</article-id>
              <article-id pub-id-type="pmc-uid">6380471</article-id>
              <article-id pub-id-type="pmid">29454501</article-id>
              <article-id pub-id-type="publisher-id">S0261-5614(18)30052-9</article-id>
              <article-id pub-id-type="doi">10.1016/j.clnu.2018.01.032</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Postoperative inflammation and insulin resistance in relation to body composition, adiposity and carbohydrate treatment: A randomised controlled study<sup><xref ref-type="fn" rid="d31e554">☆</xref></sup></article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tewari</surname>
                    <given-names>Nilanjana</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Awad</surname>
                    <given-names>Sherif</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">a</xref>
                  <xref rid="aff2" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Duška</surname>
                    <given-names>František</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">c</xref>
                  <xref rid="aff4" ref-type="aff">d</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Williams</surname>
                    <given-names>Julian P.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bennett</surname>
                    <given-names>Andrew</given-names>
                  </name>
                  <xref rid="aff5" ref-type="aff">e</xref>
                  <xref rid="aff6" ref-type="aff">f</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Macdonald</surname>
                    <given-names>Ian A.</given-names>
                  </name>
                  <xref rid="aff6" ref-type="aff">f</xref>
                  <xref rid="aff7" ref-type="aff">g</xref>
                  <xref rid="fn1" ref-type="fn">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lobo</surname>
                    <given-names>Dileep N.</given-names>
                  </name>
                  <email>dileep.lobo@nottingham.ac.uk</email>
                  <xref rid="aff1" ref-type="aff">a</xref>
                  <xref rid="aff7" ref-type="aff">g</xref>
                  <xref rid="cor1" ref-type="corresp">∗</xref>
                  <xref rid="fn1" ref-type="fn">1</xref>
                </contrib>
              </contrib-group>
              <aff id="aff1"><label>a</label>Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK</aff>
              <aff id="aff2"><label>b</label>The East-Midlands Bariatric and Metabolic Institute (EMBMI), Derby Teaching Hospitals NHS Foundation Trust, Royal Derby Hospital, Derby DE22 3NE, UK</aff>
              <aff id="aff3"><label>c</label>Department of Anaesthesia and Intensive Care, Kralovske Vinohrady University Hospital and The Third Faculty of Medicine, Prague, Czech Republic</aff>
              <aff id="aff4"><label>d</label>Department of Critical Care, Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham NG7 2UH, UK</aff>
              <aff id="aff5"><label>e</label>FRAME Laboratory, School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK</aff>
              <aff id="aff6"><label>f</label>School of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK</aff>
              <aff id="aff7"><label>g</label>MRC/ARUK Centre for Musculoskeletal Ageing Research, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK</aff>
              <author-notes>
                <corresp id="cor1"><label>∗</label>Corresponding author. Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, Nottingham University Hospitals, Queen's Medical Centre, Nottingham NG7 2UH, UK. Fax: +44 115 8231160. <email>dileep.lobo@nottingham.ac.uk</email></corresp>
                <fn id="fn1">
                  <label>1</label>
                  <p id="ntpara0015">Joint senior authors.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="pmc-release">
                <day>1</day>
                <month>2</month>
                <year>2019</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
              <pub-date pub-type="ppub">
                <month>2</month>
                <year>2019</year>
              </pub-date>
              <volume>38</volume>
              <issue>1</issue>
              <fpage>204</fpage>
              <lpage>212</lpage>
              <history>
                <date date-type="received">
                  <day>25</day>
                  <month>1</month>
                  <year>2018</year>
                </date>
                <date date-type="accepted">
                  <day>25</day>
                  <month>1</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2018 The Author(s)</copyright-statement>
                <copyright-year>2018</copyright-year>
                <license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
                </license>
              </permissions>
              <abstract id="abs0010">
                <title>Summary</title>
                <sec>
                  <title>Background &amp; aims</title>
                  <p>The aims of this study were to identify whether differences in distribution of adipose tissue and skeletal muscle in obese and non-obese individuals contribute to the magnitude of the postoperative inflammatory response and insulin resistance, with and without preoperative treatment with carbohydrate drinks.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p>Thirty-two adults (16 obese/16 non-obese) undergoing elective major open abdominal surgery participated in this 2 × 2 factorial, randomised, double-blind, placebo-controlled study. Participants received Nutricia preOp<sup>®</sup> or placebo (800 ml on the night before surgery/400 ml 2–3 h preoperatively) after stratifying for obesity. Insulin sensitivity was measured using the hyperinsulinaemic-euglycaemic clamp preoperatively and on the 1st postoperative day. Vastus lateralis, omental and subcutaneous fat biopsies were taken pre- and postoperatively and analysed after RNA extraction. The primary endpoint was within subject differences in insulin sensitivity.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>Major abdominal surgery was associated with a 42% reduction in insulin sensitivity from mean(SD) M value of 37.3(11.8) μmol kg<sup>−1</sup> fat free mass (FFM) to 21.7(7.4) μmol kg<sup>−1</sup> FFM, but this was not influenced by obesity or preoperative carbohydrate treatment. Activation of the triggering receptor expressed on myeloid cells (TREM1) pathway was seen in response to surgery in omental fat samples. In postoperative muscle samples, gene expression differences indicated activation of the peroxisome proliferator-activated receptor (PPAR-α)/retinoid X-receptor (RXR-α) pathway in obese but not in non-obese participants. There were no significant changes in gene expression pathways associated with carbohydrate treatment.</p>
                </sec>
                <sec>
                  <title>Conclusion</title>
                  <p>The reduction in insulin sensitivity associated with major abdominal surgery was confirmed but there were no differences associated with preoperative carbohydrates or obesity.</p>
                </sec>
              </abstract>
              <kwd-group id="kwrds0010">
                <title>Keywords</title>
                <kwd>Metabolic response</kwd>
                <kwd>Carbohydrate</kwd>
                <kwd>Obesity</kwd>
                <kwd>Insulin resistance</kwd>
                <kwd>Abdominal surgery</kwd>
                <kwd>Inflammation</kwd>
              </kwd-group>
              <kwd-group id="kwrds0015">
                <title>Abbreviations</title>
                <kwd>ADIPOQ, Adipose c1Q and collagen domain containing</kwd>
                <kwd>BMI, Body mass index</kwd>
                <kwd>CEBP, CCAAT enhancer binding protein</kwd>
                <kwd>CIDEA, Cell death inducing DFFA-like effector A</kwd>
                <kwd>CRP, C-reactive protein</kwd>
                <kwd>CT, computed tomography</kwd>
                <kwd>DAVID, database for annotation visualisation and integrated discovery</kwd>
                <kwd>DXA, dual X-ray absorptiometry</kwd>
                <kwd>FFA, free fatty acid</kwd>
                <kwd>FOXO, forkhead box O</kwd>
                <kwd>IPA, Ingenuity pathway analysis</kwd>
                <kwd>IR, insulin resistance</kwd>
                <kwd>IL, interleukin</kwd>
                <kwd>KEGG, Kyoto encyclopaedia of genes and genomes</kwd>
                <kwd>MYD88, myeloid differentiation primary response 88</kwd>
                <kwd>MURF 1, muscle ring finger 1</kwd>
                <kwd>PACS, picture archiving and communication system</kwd>
                <kwd>PDK, pyruvate dehydrogenase kinase</kwd>
                <kwd>PI3K/Akt1, phosphotidyl inositol 3-kinase/protein kinase B</kwd>
                <kwd>PPAR, peroxisome proliferator activated receptor</kwd>
                <kwd>SOD1, superoxide dismutase</kwd>
                <kwd>TAG, triacylglycerol</kwd>
                <kwd>TNF-α, tumour necrosis factor α</kwd>
                <kwd>TRIM 63, tripartite motif containing 63</kwd>
                <kwd>RXR, retinoid X receptor</kwd>
                <kwd>VL, vastus lateralis</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="sec1">
              <label>1</label>
              <title>Introduction</title>
              <p id="p0010">Major surgery induces inflammation and metabolic stress, processes which may be exacerbated by pre- and postoperative starvation, leading to postoperative insulin resistance (IR) <xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib3" ref-type="bibr">[3]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>, <xref rid="bib5" ref-type="bibr">[5]</xref>. IR is a state in which, under hyperinsulinaemic-euglycaemic conditions, glucose uptake is below the lowest quartile for the population under investigation <xref rid="bib6" ref-type="bibr">[6]</xref>, and obese individuals may be more prone to develop IR <xref rid="bib5" ref-type="bibr">[5]</xref>.</p>
              <p id="p0015">As IR is associated with an increase in postoperative complications <xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>, <xref rid="bib5" ref-type="bibr">[5]</xref>, measures to attenuate it may be beneficial. Some studies have suggested that administration of carbohydrate polymer (e.g. maltodextrin) drinks up to 2 h preoperatively may reduce postoperative IR <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib9" ref-type="bibr">[9]</xref>. However, three meta-analyses have not shown a reduction in complications or overall hospital stay when patients receiving carbohydrate treatment were compared with those receiving placebo or no treatment <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib11" ref-type="bibr">[11]</xref>, <xref rid="bib12" ref-type="bibr">[12]</xref>. Nevertheless, a one-day reduction in hospital stay was seen in patients undergoing major abdominal surgery after carbohydrate treatment <xref rid="bib11" ref-type="bibr">[11]</xref>.</p>
              <p id="p0020">The aims of this study were to identify whether differences in the distribution and physiology of adipose tissue and skeletal muscle in obese and non-obese individuals contribute to variation in the magnitude of the postoperative inflammatory response and IR, with and without preoperative carbohydrate treatment.</p>
            </sec>
            <sec id="sec2">
              <label>2</label>
              <title>Methods</title>
              <sec id="sec2.1">
                <label>2.1</label>
                <title>Study design, ethics, trial registration and inclusion and exclusion criteria</title>
                <p id="p0025">This 2 × 2 factorial, randomised, double-blind, placebo-controlled study was set in a university teaching hospital. Adults aged 18–80 years undergoing elective major open abdominal surgery were enrolled after providing informed written consent. The National Research Ethics Service approved the study (11/EM/0232), which was registered at <ext-link ext-link-type="uri" xlink:href="http://www.controlled-trials.com" id="intref0010">www.controlled-trials.com</ext-link> (ISRCTN16597586). Exclusion criteria were pregnancy, &gt;10% weight loss in the preceding 3 months, metabolic and endocrine disorders including diabetes mellitus and steroid usage, known gastro-oesophageal reflux disease or hiatus hernia, history of pulmonary aspiration, and suspicion of alcohol or drug abuse. Participants were classified as obese (BMI ≥30 kg m<sup>−2</sup> or waist circumference ≥94 cm in men or ≥80 cm in women) (n = 16) or non-obese (n = 16).</p>
              </sec>
              <sec id="sec2.2">
                <label>2.2</label>
                <title>Interventions, randomisation and blinding</title>
                <p id="p0030">Central computerised randomisation was performed for participants to receive Nutricia preOp<sup>®</sup> (Nutricia Clinical Care, Trowbridge, UK) or placebo (Tovali Sugar Free Whole Lemon Drink diluted 1:4 with water, Tovali Ltd., Carmarthen, UK) (<xref rid="tbl1" ref-type="table">Table 1</xref>) after stratifying for obesity. The drinks were prepared in identical opaque bottles by a person not involved in the research. Investigators remained blinded until all analyses were completed.<table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Composition of study drinks.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Constituents (per 100 ml)</th><th>Unit</th><th>Nutricia preOp<sup>®</sup></th><th>Placebo</th></tr></thead><tbody><tr><td>Energy</td><td>kcal<break/>kJ</td><td>50<break/>215</td><td>1.6<break/>7</td></tr><tr><td>Protein</td><td>g</td><td>0</td><td>0.02</td></tr><tr><td>Carbohydrate</td><td>g</td><td>12.6</td><td>0.04</td></tr><tr><td> Maltodextrin</td><td>g</td><td>10</td><td>0</td></tr><tr><td> Sugars</td><td>g</td><td>2.1</td><td>0.04</td></tr><tr><td>Fat</td><td>g</td><td>0</td><td>Trace</td></tr><tr><td>Sodium</td><td>mg (mmol)</td><td>50 (2.2)</td><td>20 (0.9)</td></tr><tr><td>Potassium</td><td>mg (mmol)</td><td>122 (3.1)</td><td>Unavailable</td></tr><tr><td>Chloride</td><td>mg (mmol)</td><td>6 (0.2)</td><td>Unavailable</td></tr><tr><td>Calcium</td><td>mg (mmol)</td><td>6 (0.1)</td><td>Unavailable</td></tr><tr><td>Phosphorus</td><td>mg (mmol)</td><td>1 (0.0)</td><td>Unavailable</td></tr><tr><td>Magnesium</td><td>mg (mmol)</td><td>1 (0.0)</td><td>Unavailable</td></tr><tr><td>Water</td><td>g</td><td>92</td><td>80</td></tr></tbody></table></table-wrap></p>
              </sec>
              <sec id="sec2.3">
                <label>2.3</label>
                <title>End points and sample size</title>
                <p id="p0035">The primary endpoint was within subject differences in perioperative insulin sensitivity (as measured by the hyperinsulinaemic-euglycaemic clamp [HEC] <xref rid="bib13" ref-type="bibr">[13]</xref>) among obese, non-obese, carbohydrate treated and placebo treated participants. Secondary endpoints were correlation between body composition and changes in IR, differences in inflammatory cytokine gene expression, and differences in muscle and fat genes controlling carbohydrate and fat oxidation and insulin signalling. Complications within 30 days of the operation were recorded according to Clavien-Dindo classification <xref rid="bib14" ref-type="bibr">[14]</xref>.</p>
                <p id="p0040">Based on a previous study <xref rid="bib7" ref-type="bibr">[7]</xref> and with an estimated standard deviation of 10% in measurements of insulin sensitivity, 8 participants were required to detect pair-wise differences of 27% between the two 2 groups (carbohydrate <italic>versus</italic> placebo) with a power of 80% at a significance level of 0.05. Therefore, 8 participants were recruited to each of the four arms.</p>
              </sec>
              <sec id="sec2.4">
                <label>2.4</label>
                <title>Experimental methods</title>
                <p id="p0045">Participants had a preoperative screening visit (P1) in the week before surgery. Height, weight, and hip and waist circumferences were measured, and dual X-ray absorptiometry (DXA) scan and HEC performed. Participants were randomised to receive Nutricia preOp<sup>®</sup> containing 50 g maltodextrin in 400 ml or placebo and consumed 800 ml on the evening before and 400 ml 2–3 h before anaesthesia (<xref rid="tbl1" ref-type="table">Table 1</xref>). A second HEC was performed on the first postoperative day (P2) (<xref rid="tbl2" ref-type="table">Table 2</xref>).<table-wrap position="float" id="tbl2"><label>Table 2</label><caption><p>Time points for blood sampling.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>P1</th><th>S1</th><th>S2</th><th>P2</th></tr></thead><tbody><tr><td>Before surgery (at commencement of preoperative clamp)</td><td>Day of surgery, before knife to skin</td><td>Day of surgery, after closure of the abdomen</td><td>Post-operative day 1 (at commencement of postoperative clamp)</td></tr></tbody></table></table-wrap></p>
                <sec id="sec2.4.1">
                  <label>2.4.1</label>
                  <title>Hyperinsulinaemic-euglycaemic clamp (HEC) <xref rid="bib13" ref-type="bibr">[13]</xref>.</title>
                  <p id="p0050">After an overnight fast, two intravenous cannulae were placed, one in an antecubital vein for the infusion of insulin (Actrapid, Novo Nordisk, Denmark) and 10% glucose, and the other retrograde into a dorsal hand vein which was kept in a hot box for sampling of arterialised blood. A baseline blood sample for measurement of fasting blood glucose, and inflammatory and hormonal markers was taken. After a 10-min priming infusion, insulin infusion (1 unit ml<sup>−1</sup> 0.9% saline) was held constant at 120 mIU m<sup>−2</sup> min<sup>−1</sup> for 110 min. Blood glucose concentration was determined every 5 min using the YSI 2300 Stat Plus (YSI Inc., Yellow Springs, OH). Blood glucose concentration was clamped at 4.5 mmol l<sup>−1</sup> by infusion of variable amounts of glucose. The total body glucose disposal rate (M-value) was calculated during the final 15 min (steady-state) and was used as a measure of insulin sensitivity <xref rid="bib13" ref-type="bibr">[13]</xref>. Insulin concentrations were measured during the clamp to allow calculation of M/I. (<xref rid="appsec1" ref-type="sec">Supplementary Digital Content Fig. 1</xref>).</p>
                </sec>
                <sec id="sec2.4.2">
                  <label>2.4.2</label>
                  <title>Body composition analysis</title>
                  <p id="p0055">One CT image slice for each participant at the third lumbar vertebra level was selected and the images were analysed using SliceOmatic V4.2 software (Tomovision, Montreal, Canada) to quantify fat free mass (FFM), fat mass (FM), skeletal muscle index (SMI) and myosteatosis (<xref rid="appsec1" ref-type="sec">Supplemental Digital Content – Experimental</xref>) <xref rid="bib15" ref-type="bibr">[15]</xref>, <xref rid="bib16" ref-type="bibr">[16]</xref>, <xref rid="bib17" ref-type="bibr">[17]</xref>, <xref rid="bib18" ref-type="bibr">[18]</xref>, <xref rid="bib19" ref-type="bibr">[19]</xref>, <xref rid="bib20" ref-type="bibr">[20]</xref>.</p>
                </sec>
                <sec id="sec2.4.3">
                  <label>2.4.3</label>
                  <title>Collection and analysis of blood samples</title>
                  <p id="p0060">The concentrations of tumour necrosis factor-α (TNFα), interleukin-6 (IL-6), C-reactive protein (CRP), triacylglycerol (TAG), blood glucose, plasma cortisol, serum insulin, serum non-esterified fatty acids (NEFA) and free fatty acids (FFA) were measured at four time points (<xref rid="tbl2" ref-type="table">Table 2</xref>). Assays are described in the <xref rid="appsec1" ref-type="sec">Supplemental Digital Content – Experimental</xref>. The TNF assay was not highly sensitive, with detection limit of 1 pg ml<sup>−1</sup>.</p>
                </sec>
                <sec id="sec2.4.4">
                  <label>2.4.4</label>
                  <title>Skeletal muscle and subcutaneous adipose tissue biopsies</title>
                  <p id="p0065">Vastus lateralis (VL) muscle biopsies were obtained using a Weil-Blakesley forceps (medizintechnik, Stuttgart, Germany). Subcutaneous adipose tissue and omental tissue were also collected. The samples were snap frozen in liquid nitrogen and stored at −80 °C.</p>
                </sec>
                <sec id="sec2.4.5">
                  <label>2.4.5</label>
                  <title>RNA extraction</title>
                  <p id="p0070">Biopsy samples were defrosted and total RNA was isolated using Tri reagent according to the manufacturer's instructions. The RNA pellet was air-dried for 10 min and then resuspended in 50 μL of RNase free water, and cDNA was prepared and quantified (<xref rid="appsec1" ref-type="sec">Supplemental Digital Content – Experimental</xref>).</p>
                </sec>
                <sec id="sec2.4.6">
                  <label>2.4.6</label>
                  <title>TaqMan low density gene array analysis</title>
                  <p id="p0075">A custom TaqMan<sup>®</sup> Array Micro Fluidic Card was designed for each tissue for gene array analysis (<xref rid="appsec1" ref-type="sec">Supplemental Digital Content – Experimental and Supplemental Digital Content Tables 1 and 2</xref>).</p>
                </sec>
              </sec>
              <sec id="sec2.5">
                <label>2.5</label>
                <title>Statistical analyses</title>
                <p id="p0080">Statistical analysis was performed with SPSS<sup>®</sup> for Windows™ v22 software (IBM, Armonk, NY) and GraphPad Prism v6.04 (GraphPad Software Inc., La Jolla, CA). Data are presented as mean (SE or SD) or median (IQR). The paired and independent samples <italic>t</italic>-tests were used for parametric paired and unpaired data, respectively. The Wilcoxon signed rank and Mann–Whitney U tests were used for non-parametric paired and unpaired data, respectively. The Chi square test was used for categorical data.</p>
                <p id="p0085">Comparisons between the study time points for parametric and non-parametric data were made using the repeated measures ANOVA or the Kruskal–Wallis tests, respectively. Two-tailed p values, with Welch's correction, are reported and differences were considered significant at p &lt; 0.05.</p>
              </sec>
            </sec>
            <sec id="sec3">
              <label>3</label>
              <title>Results</title>
              <p id="p0090">The demographics of the 32 participants (<xref rid="fig1" ref-type="fig">Fig. 1</xref>) are shown in <xref rid="tbl3" ref-type="table">Table 3</xref> and surgical procedures are listed in <xref rid="appsec1" ref-type="sec">Supplemental Digital Content Table 3</xref>.<fig id="fig1"><label>Fig. 1</label><caption><p>CONSORT flow diagram.</p></caption><graphic xlink:href="gr1"/></fig><table-wrap position="float" id="tbl3"><label>Table 3</label><caption><p>Participant demographics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Parameter</th><th>Total (n = 32)</th><th>Obese (n = 16)</th><th>Non-obese (n = 16)</th><th>Carbohydrate treated (n = 16)</th><th>Placebo treated (n = 16)</th><th>Obese + carbohydrate treated (n = 8)</th><th>Obese + placebo treated (n = 8)</th><th>Non-obese + carbohydrate treated (n = 8)</th><th>Non-obese + placebo treated (n = 8)</th></tr></thead><tbody><tr><td>Age [median (IQR)] yrs</td><td>61 (50–67)</td><td>61 (58–66)</td><td>63 (46–68)</td><td>62 (46–66)</td><td>61 (51–68)</td><td>60 (44–64)</td><td>63 (52–68)</td><td>65 (51–72)</td><td>61 (51–65)</td></tr><tr><td>Gender (M:F)</td><td>22:10</td><td>12: 4</td><td>10: 6</td><td>10:6</td><td>12:4</td><td>5:3</td><td>7:1</td><td>5:3</td><td>5:3</td></tr><tr><td>BMI [mean (SD)] kg m<sup>−2</sup></td><td>28.3 (5.5)</td><td>31.0 (6.1)</td><td>25.7 (3.0)</td><td>29.6 (6.3)</td><td>27 (4.3)</td><td>30.3 (8.3)</td><td>28.9 (3.8)</td><td>27.5 (5.0)</td><td>26.4 (3.6)</td></tr><tr><td>Waist circumference [median (IQR)] cm</td><td>93 (86.5–106.5)</td><td>106.5 (98.6–113)</td><td>87.5 (79–92.4)</td><td>95 (86.3–110.8)</td><td>92.9 (85.8–105.8)</td><td>98.6 (92–107.5)</td><td>91.5 (74.6–106.5)</td><td>90.5 (82.5–112)</td><td>92.9 (90–99.6)</td></tr><tr><td>Operating time (median, IQR) min</td><td>180 (128–240)</td><td>160 (128–246)</td><td>182 (133–222.5)</td><td>152.5 (121–199.5)</td><td>188 (152–300)</td><td>126 (115.5–182.5)</td><td>196.5 (171.5–306.5)</td><td>168 (143–223)</td><td>160 (120–300)</td></tr><tr><td>Blood loss [mean (SD)] ml</td><td>542 (465)</td><td>631 (533)</td><td>469 (405)</td><td>570 (216.5–920.5)</td><td>400 (108–695)</td><td>701 (735)</td><td>528 (265)</td><td>535 (341)</td><td>429 (548)</td></tr></tbody></table></table-wrap></p>
              <sec id="sec3.1">
                <label>3.1</label>
                <title>Hyperinsulinaemic-euglycaemic clamps</title>
                <p id="p0095">There was a 42% decrease (p &lt; 0.001) in insulin sensitivity (<xref rid="tbl4" ref-type="table">Table 4</xref>) from M value (mean (SD) of 37.3 (11.8) μmol kg<sup>−1</sup> FFM to 21.7 (7.4) μmol kg<sup>−1</sup> FFM, in both obese and non-obese subjects between the preoperative visit and the first postoperative day. However, there was no difference in the magnitude of change in insulin sensitivity between obese and non-obese participants or in those who received and did not receive carbohydrate drinks (<xref rid="tbl4" ref-type="table">Table 4</xref>). Plasma insulin concentrations were measured and summarised in <xref rid="appsec1" ref-type="sec">Supplemental Digital Content Fig. 1.</xref> As the magnitude of change in insulin sensitivity was equivalent when comparing M values pre- and postoperatively or M/I, M values were used for all analyses.<table-wrap position="float" id="tbl4"><label>Table 4</label><caption><p>M values at visit 1 and 2 (mean (SD)) and postoperative reduction insulin sensitivity in obese <italic>vs</italic>. non-obese participants and those receiving carbohydrate <italic>vs</italic>. placebo. There was no influence of gender, age, cancer status or length of surgical procedure on the change in insulin sensitivity (data not shown). The reduction in insulin sensitivity between the preoperative (100%) and postoperative M values was statistically significant (p &lt; 0.001) for all groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Groups</th><th>All</th><th>Obese</th><th>Non-obese</th><th>Difference between groups</th></tr></thead><tbody><tr><td>All</td><td>(n = 32)</td><td>(n = 16)</td><td>(n = 16)</td><td rowspan="4">p = 0.38</td></tr><tr><td>Preoperative M value mean (SD) μmol kg<sup>−1</sup></td><td>37.3 (11.8)</td><td>41.6 (11.7)</td><td>33.1 (10.7)</td></tr><tr><td>Postoperative M value mean (SD) μmol kg<sup>−1</sup></td><td>21.7 (7.4)</td><td>24.5 (7.6)</td><td>19.2 (7.4)</td></tr><tr><td>Reduction in insulin sensitivity</td><td>42%</td><td>41%</td><td>42%</td></tr><tr><td>Carbohydrate treated</td><td>(n = 16)</td><td>(n = 8)</td><td>(n = 8)</td><td rowspan="4">p = 0.19</td></tr><tr><td>Preoperative M value mean (SD) μmol kg<sup>−1</sup></td><td>36.2 (11.4)</td><td>32.5 (8.8)</td><td>40.3 (13.0)</td></tr><tr><td>Postoperative M value mean (SD) μmol kg<sup>−1</sup></td><td>19.5 (6.1)</td><td>18.2 (6.3)</td><td>21 (6.0)</td></tr><tr><td>Reduction in insulin sensitivity</td><td>46%</td><td>44%</td><td>48%</td></tr><tr><td>Placebo</td><td>(n = 16)</td><td>(n = 8)</td><td>(n = 8)</td><td rowspan="4">p = 0.06</td></tr><tr><td>Preoperative M value mean (SD) μmol kg<sup>−1</sup></td><td>38.5 (12.6)</td><td>33.8 (13.3)</td><td>43.1 (10.8)</td></tr><tr><td>Postoperative M value mean (SD) μmol kg<sup>−1</sup></td><td>22 (8.5)</td><td>17.6 (8.4)</td><td>26.7 (8.9)</td></tr><tr><td>Reduction in insulin sensitivity</td><td>43%</td><td>48%</td><td>38%</td></tr><tr><td>Difference between groups</td><td>p = 0.67</td><td>p = 0.23</td><td>p = 0.23</td><td/></tr></tbody></table></table-wrap></p>
              </sec>
              <sec id="sec3.2">
                <label>3.2</label>
                <title>Body composition and insulin sensitivity</title>
                <p id="p0100">There was some correlation between DXA and CT (<xref rid="appsec1" ref-type="sec">Supplemental Digital Content Table 4</xref>) for both fat mass (r<sup>2</sup> = 0.486, p &lt; 0.001) and fat free mass (r<sup>2</sup> = 0.658, p &lt; 0.001). There was no correlation between the presence of sarcopenia and preoperative (r<sup>2</sup> = 0.233, p = 0.594) or postoperative (r<sup>2</sup> = 0.318, p = 0.120) IR. Myosteatosis was present in 29.6% participants who had preoperative CT scans. Although there was no correlation between the presence of myosteatosis and sarcopenia (p = 0.152), there was significant correlation between presence of myosteatosis and postoperative IR (r<sup>2</sup> = 0.746, p = 0.012).</p>
              </sec>
              <sec id="sec3.3">
                <label>3.3</label>
                <title>Complications</title>
                <p id="p0105">There was no significant difference in 30-day postoperative complications between obese and non-obese patents and those receiving carbohydrate treatment or placebo, when graded according to the Clavien–Dindo classification <xref rid="bib14" ref-type="bibr">[14]</xref>. Of the 16 obese patients, 9 had no complications, 3 had Grade I and 4 Grade II complications. Of the 16 non-obese patients, 10 had no complications, 3 Grade I, 2 Grade II and 1 Grade IIIb complications (p = 0.633, Chi-square test). Of the 16 patients who received preoperative carbohydrates, 13 had no complications, 2 Grade I, and 1 Grade II complications. Of the 16 patients receiving placebo, 6 had no complications, 4 Grade I, 5 Grade II and 1 Grade IIIb complications (p = 0.075, Chi-square test). There was no 30-day or in-hospital mortality.</p>
              </sec>
              <sec id="sec3.4">
                <label>3.4</label>
                <title>Metabolic data</title>
                <p id="p0110">Concentrations of FFA, TAG, Cortisol and cytokines are shown in <xref rid="fig2" ref-type="fig">Fig. 2</xref>. There was a significant increase in IL-6 concentration from the preoperative time point to the end of surgery (p &lt; 0.0001) and there was a significant increase in CRP between the end of surgery and the first postoperative day (p &lt; 0.001). There was no significant difference between obese and non-obese participants in IL-6 (p = 0.203), CRP (p = 0.645), FFA (p = 0.446), cortisol (p = 0.322) or TNFα (p = 0.101) concentrations (data in figure – combined placebo and carbohydrate treated data as there were no differences between groups).<fig id="fig2"><label>Fig. 2</label><caption><p>Perioperative changes in concentrations of interleukin 6 (IL-6), tumour necrosis factor α (TNF-α), cortisol, C-reactive protein (CRP), triacylglycerol (TAG) and free fatty acid (FFA). P1 = preoperative, S1 = start of surgery, S2 = end of surgery and P2 = first postoperative day. **p &lt; 0.05, ***p &lt; 0.001.</p></caption><graphic xlink:href="gr2"/></fig></p>
              </sec>
              <sec id="sec3.5">
                <label>3.5</label>
                <title>Gene expression analysis of muscle and fat biopsies</title>
                <p id="p0115">Taqman low density arrays were designed to contain assays for a selection of genes involved in carbohydrate and lipid metabolism, insulin signalling, muscle atrophy and inflammatory pathways.</p>
                <sec id="sec3.5.1">
                  <label>3.5.1</label>
                  <title>Effects of surgery</title>
                  <p id="p0120">Omental fat sample gene expression results indicated an elevation of inflammatory pathway genes in response to surgery. Database for annotation visualisation and integrated discovery (DAVID) analysis of omental fat data revealed that the top two enriched Kyoto encyclopaedia of genes and genomes (KEGG) pathways highlighted were ‘regulation of cytokine production’ (NLRP3, IRAK3, IL1B, IL18, C3, HIF1A, CASP1, TGFB1, ADIPOQ, MYD88, IL6, PPARG, IL10, TNF, SOD1, CIDEA; p = 9.1 × 10<sup>−16</sup>) and ‘positive regulation of cytokine production’ (IRAK3, CEBPB, C3, ADIPOQ, PPARG, IL10, CIDEA; p = 2.1 × 10<sup>−10</sup>). Activation of the triggering receptor expressed on myeloid cells (TREM1) pathway, which amplifies inflammatory signalling, was also seen in response to surgery in omental fat samples (<xref rid="appsec1" ref-type="sec">Supplemental Digital Content Fig. 2</xref>). This was demonstrated by a positive Z score (2.646, p &lt; 0.0001) on ingenuity pathway analysis (IPA). The Z score in IPA infers the activation state of predicted transcriptional regulators based on experimentally observed gene expression or transcription events.</p>
                  <p id="p0125">In VL, there were surprisingly few changes in gene expression in response to surgery, however there was a significant decrease in expression of tripartite motif containing 63 (TRIM 63) gene, also known as muscle ring finger 1 (MURF-1) between pre- and postoperative samples.</p>
                </sec>
                <sec id="sec3.5.2">
                  <label>3.5.2</label>
                  <title>Differences between obese and non-obese participants</title>
                  <p id="p0130">In postoperative VL samples, gene expression differences indicated increased activation of the peroxisome proliferator-activated receptor (PPAR-α)/retinoid X-receptor (RXR-α) pathway in obese compared with non-obese participants (<xref rid="appsec1" ref-type="sec">Supplemental Digital Content Fig. 3</xref>). This was demonstrated by a negative Z score (−1.000, p &lt; 0.0001) on IPA. This was confirmed on DAVID analysis which highlighted ‘fatty acid metabolism’ (p = 2.8 × 10<sup>−14</sup>) and PPAR signalling pathway (p = 6.0 × 10<sup>−13</sup>) as the top two enriched pathways from KEGG.</p>
                </sec>
                <sec id="sec3.5.3">
                  <label>3.5.3</label>
                  <title>Effects of carbohydrate loading</title>
                  <p id="p0135">In VL samples, there were no significant differences in postoperative gene expression between carbohydrate and placebo treated participants. In obese participants, in VL samples, no differences were seen postoperatively between carbohydrate and placebo treatments. There were individual gene expression changes in non-obese carbohydrate loaded participants compared with those receiving placebo but these did not indicate major changes in any particular metabolic or signalling pathway. Postoperatively, in omental fat, there were no differences between samples from carbohydrate-treated or placebo-treated participants. In abdominal fat, there was little influence of carbohydrate treatment or obesity on perioperative changes in gene expression. In particular, carbohydrate loading had no discernible effect in any tissue upon expression of genes involved in carbohydrate metabolism or insulin signalling.</p>
                </sec>
              </sec>
            </sec>
            <sec id="sec4">
              <label>4</label>
              <title>Discussion</title>
              <p id="p0140">This study has shown that although insulin sensitivity was decreased after major surgery in both obese and non-obese subjects, preoperative carbohydrate treatment or obesity did not have an impact on the magnitude of change. In addition, gene expression analyses suggested that both lipid and carbohydrate metabolism pathways were activated by surgery, but not altered by carbohydrate treatment. Although previous reports suggest increased risk of morbidity in obese patients undergoing surgery <xref rid="bib15" ref-type="bibr">[15]</xref>, in the present study, there were no differences in postoperative complications between obese and non-obese participants nor between carbohydrate and placebo treated participants. The Clavien–Dindo classification <xref rid="bib14" ref-type="bibr">[14]</xref> is a standard and accepted means of reporting postoperative complications. Although this study was not powered to detect a difference in complication rate, previous meta-analyses have not shown a difference in postoperative complications between carbohydrate and placebo treated individuals <xref rid="bib11" ref-type="bibr">[11]</xref>, <xref rid="bib12" ref-type="bibr">[12]</xref>.</p>
              <p id="p0145">It has been suggested that preoperative carbohydrate treatment reduces the magnitude of postoperative IR <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib9" ref-type="bibr">[9]</xref>. In a small study in colorectal surgery (n = 14), administration of 100 g oral carbohydrate on the night before and 50 g on the morning of surgery was associated with less reduction in whole body glucose disposal compared with the fasted group <xref rid="bib7" ref-type="bibr">[7]</xref>. There have been two other small studies utilising the HEC which have demonstrated a reduction in IR in preoperative carbohydrate treated patients compared with placebo <xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib9" ref-type="bibr">[9]</xref>. In a recent animal study, postoperative whole body glucose disposal rate was higher after carbohydrate treatment than fasting and this correlated negatively with muscle PDK4 protein expression <xref rid="bib16" ref-type="bibr">[16]</xref>. The same study group demonstrated, in pigs, that a single dose of carbohydrate preoperatively was sufficient to reduce postoperative IR, as measured by the HEC <xref rid="bib17" ref-type="bibr">[17]</xref>. However, a recent multiple-treatments meta-analysis on 62 participants studied using HEC showed no significant difference in any of the comparisons (between carbohydrate treatment and fasting, water or placebo) <xref rid="bib12" ref-type="bibr">[12]</xref>.</p>
              <p id="p0150">Serum markers of the inflammatory response increased with surgery. There was no significant change in TNF-α but there was a significant change in IL-6. This is in keeping with previous studies of major surgery and suggests that IL-6 may be the main driver of the postoperative response <xref rid="bib18" ref-type="bibr">[18]</xref> while TNF-α is involved in the inflammatory response to sepsis <xref rid="bib19" ref-type="bibr">[19]</xref>.</p>
              <p id="p0155">Gene expression analysis of abdominal fat, VL and omental fat before and after surgery indicated that adaptive changes in gene expression did occur in response to surgery, but not in response to carbohydrate treatment. Changes in the PPARα/RXRα pathway were demonstrated in postoperative VL samples of obese compared with non-obese participants. PPARα is a master transcriptional regulator of fatty acid oxidation <xref rid="bib19" ref-type="bibr">[19]</xref>, <xref rid="bib20" ref-type="bibr">[20]</xref>, <xref rid="bib21" ref-type="bibr">[21]</xref>, <xref rid="bib22" ref-type="bibr">[22]</xref> and the PPARα pathway is induced during fasting. In mouse models, PPARα agonists reduced adiposity, decreased muscle and hepatic steatosis and consequently improved insulin sensitivity <xref rid="bib23" ref-type="bibr">[23]</xref>, <xref rid="bib24" ref-type="bibr">[24]</xref>, <xref rid="bib25" ref-type="bibr">[25]</xref>, <xref rid="bib26" ref-type="bibr">[26]</xref>. Activation of this pathway in the present study may be reflective, in part, of preoperative fasting but this does not account for the increased activation in obese compared with non-obese participants. There are some parallels with the Randle hypothesis which suggested in rats that substrate competition between NEFAs and glucose served as an energy source for muscle <xref rid="bib27" ref-type="bibr">[27]</xref>, resulting in a relative increase in fat oxidation compared with carbohydrate metabolism in response to increased NEFAs.</p>
              <p id="p0160">Muscle atrophy has been observed in response to protein energy malnutrition and fasting, but is also a feature of immobility, diabetes, cancer cachexia and sepsis <xref rid="bib28" ref-type="bibr">[28]</xref>. An increased expression of TRIM63 gene (MURF-1) has been observed in models of muscle wasting, including fasting <xref rid="bib29" ref-type="bibr">[29]</xref>. However, in a study examining skeletal muscle of volunteers subjected to a short-term fast, there was no significant change in MURF-1 expression. Therefore, the changes observed in the present study in TRIM63 and related genes are unlikely to be due to fasting alone <xref rid="bib30" ref-type="bibr">[30]</xref>. Induction of TRIM63 has been observed in immobilisation-induced muscle atrophy <xref rid="bib30" ref-type="bibr">[30]</xref> but the length of surgery in the present study is unlikely to have been sufficient to induce atrophy. In this study, TRIM 63 gene expression was decreased postoperatively in VL samples, which is counterintuitive in the context of the current literature. In addition, FBOX032 (atrogin) expression decreased. Atrogin belongs to the ubiquitin proteasome pathway, the primary pathway involved in intracellular protein degradation in skeletal muscle <xref rid="bib26" ref-type="bibr">[26]</xref>. A decrease in TRIM 63 (MURF 1) and atrogin (FBOX032) would suggest adaptation to counteract myofibril degradation (<xref rid="fig3" ref-type="fig">Fig. 3</xref>). Transgenic mice overexpressing TRIM63 did not present with muscle atrophy but had hyperinsulinemia and reduced hepatic glycogen stores <xref rid="bib31" ref-type="bibr">[31]</xref>. The changes demonstrated in the present study have also been described following stimulation of a catabolic state resulting in muscle atrophy <xref rid="bib32" ref-type="bibr">[32]</xref>.<fig id="fig3"><label>Fig. 3</label><caption><p>In surgical trauma, increased production and release of inflammatory cytokines leads to NFκB-mediated inhibition of insulin signalling and subsequent decrease in glucose uptake and utilization. Increased glucocorticoid release on the other hand will increase expression of PPARα and lead to an increase in beta oxidation of fatty acids. In concert with these changes in metabolic substrate utilization, the expression of Murf1 and Atrogin1 are decreased post operatively by and as yet unknown mechanism. The net result of these changes re glucose and protein being spared in exchange for increased utilization of fatty acids in the short-term response to surgical trauma. (AKT = protein kinase B, GRα = glucocorticoid receptor α, Murf1 = muscle RING-finger protein-1, NFκB = nuclear factor kappa-light-chain-enhancer of activated B cells, PI3K = phosphatidylinositide 3-kinase, PPARα = peroxisome proliferator-activated receptor α).</p></caption><graphic xlink:href="gr3"/></fig></p>
              <p id="p0165">The most conspicuous finding in omental fat was activation of the TREM1 pathway postoperatively. TREM1 expression has so far been studied primarily in immune cells and its activation resulted in increased production of pro-inflammatory cytokines such as IL-1β and TNFα as well as chemokines such as IL-8 and MCP-1. Surface expression of TREM1 in peripheral blood mononuclear cells was increased significantly in postoperative patients compared with controls, with an even higher expression observed in septic patients <xref rid="bib33" ref-type="bibr">[33]</xref>. In acute pancreatitis, expression of TREM-1 correlated with disease severity <xref rid="bib34" ref-type="bibr">[34]</xref>. The activation of the TREM1 pathway in omental samples postoperatively is likely to represent part of the inflammatory response to surgery.</p>
              <p id="p0170">The present study has some limitations. There was heterogeneity in terms of participant age and comorbidities. Every effort was made to ensure that procedures were comparable, in terms of length of procedure and blood loss, but in this relatively small patient group, the variability may have affected results. A standard technique of calculation of insulin dose using body surface area was used <xref rid="bib13" ref-type="bibr">[13]</xref> but this may have overestimated the insulin dose required per unit of lean mass in obese individuals and, thereby, resulted in greater glucose disposal. However, when the M value was corrected for the circulating insulin concentration during the clamp, there remained no significant difference in the change in perioperative insulin sensitivity between lean and obese individuals.</p>
              <p id="p0175">The HEC was performed with an intentionally high insulin dose to suppress hepatic (and possibly renal) gluconeogenesis and to overcome at least the expected insulin resistance of the obese group. Hence, our findings are not directly comparable with those in the literature using HEC to evaluate insulin sensitivity changes in surgical patients, but the same protocol was used pre- and postoperatively. Thus, the results demonstrate that even at these high rates of insulin infusion, postoperative IR is substantial. The glucose infused during the HEC to maintain euglycaemia is a measure of insulin sensitivity/resistance. In starvation or after trauma/surgery the insulin resistance is reflected by a lower rate of glucose infusion at a fixed insulin infusion. In both conditions, the endocrine and cytokine responses will stimulate hepatic gluconeogenesis, but the insulin infusion rate selected for this study should suppress most if not all of this increased glucose production. This can only be absolutely confirmed with tracer infusions, which were not performed in this study. Thus, it is possible there was still some residual endogenous glucose production, but this will not have offset the almost 50% reduction in glucose infusion rate in the post-surgical state.</p>
              <p id="p0180">In conclusion, the evidence for recommendation of preoperative carbohydrate treatment care is not as strong as believed previously <xref rid="bib35" ref-type="bibr">[35]</xref> and further large scale well-designed randomised controlled studies looking at patient-centred outcomes are needed before a firm conclusion can be made on its efficacy. It is also possible that due to the overall improvement in perioperative care including avoidance of prolonged preoperative starvation and introduction of other measures to reduce perioperative inflammation, the marginal gains noted in initial studies on carbohydrate treatment may not be apparent in a multimodal pathway designed to decrease the postoperative response to metabolic stress.</p>
            </sec>
            <sec id="sec5">
              <title>Author contributions</title>
              <p id="p0185">
                <list list-type="simple" id="ulist0010">
                  <list-item id="u0010">
                    <p id="p0190">NT – study design, literature search, data collection, data analysis, data interpretation, writing of the manuscript and final approval.</p>
                  </list-item>
                  <list-item id="u0015">
                    <p id="p0195">SA – study design, literature search, data interpretation, writing of the manuscript and final approval.</p>
                  </list-item>
                  <list-item id="u0020">
                    <p id="p0200">FD – study design, data collection, data interpretation, writing of the manuscript and final approval.</p>
                  </list-item>
                  <list-item id="u0025">
                    <p id="p0205">JPW – study design, data interpretation, critical review and final approval.</p>
                  </list-item>
                  <list-item id="u0030">
                    <p id="p0210">AB – study design, literature search, data analysis, data interpretation, critical review, supervision and final approval.</p>
                  </list-item>
                  <list-item id="u0035">
                    <p id="p0215">IAM – study design, data interpretation, critical review, supervision and final approval</p>
                  </list-item>
                  <list-item id="u0040">
                    <p id="p0220">DNL – study design, literature search, data interpretation, figures, writing of the manuscript, critical review, supervision and final approval.</p>
                  </list-item>
                </list>
              </p>
            </sec>
            <sec id="sec6">
              <title>Funding</title>
              <p id="p0225">This work was supported by the <funding-source id="gs1">Medical Research Council</funding-source> [grant number MR/K00414X/1], <funding-source id="gs2">Arthritis Research UK</funding-source> [grant number 19891], the <funding-source id="gs3">CORE Foundation</funding-source>, the <funding-source id="gs4">European Society for Clinical Nutrition and Metabolism (ESPEN)</funding-source>, the <funding-source id="gs5">National Institute for Health Research Nottingham Digestive Diseases Biomedical Research Unit</funding-source>, and <funding-source id="gs6">Nottingham University Hospitals Charities</funding-source>.</p>
            </sec>
            <sec id="sec7">
              <title>Role of funding bodies</title>
              <p id="p0230">The funders had no role in the study design, conduct of the study, data collection or analysis or interpretation, and writing of the paper or the decision to submit for publication. No payment has been received from any other source or agency. The corresponding author has full access to all the data in the study and has final responsibility for the decision to submit for publication.</p>
              <p id="p0235">This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily the views of the NHS, the NIHR or the Department of Health.</p>
            </sec>
            <sec id="sec8">
              <title>Conflict of interest</title>
              <p id="p0240">None of the authors has any direct conflicts of interest to declare. IAM has received research funding from Mars Inc. and serves on the advisory board of IKEA for unrelated work. DNL has received unrestricted research funding and speaker's honoraria from Fresenius Kabi, BBraun and Baxter Healthcare for unrelated work.</p>
            </sec>
          </body>
          <back>
            <ref-list id="cebib0010">
              <title>References</title>
              <ref id="bib1">
                <label>1</label>
                <element-citation publication-type="journal" id="sref1">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Awad</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Constantin-Teodosiu</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Macdonald</surname>
                      <given-names>I.A.</given-names>
                    </name>
                    <name>
                      <surname>Lobo</surname>
                      <given-names>D.N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Short-term starvation and mitochondrial dysfunction – a possible mechanism leading to postoperative insulin resistance</article-title>
                  <source>Clin Nutr</source>
                  <volume>28</volume>
                  <issue>5</issue>
                  <year>2009</year>
                  <fpage>497</fpage>
                  <lpage>509</lpage>
                  <pub-id pub-id-type="pmid">19446932</pub-id>
                </element-citation>
              </ref>
              <ref id="bib2">
                <label>2</label>
                <element-citation publication-type="journal" id="sref2">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thorell</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Nygren</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ljungqvist</surname>
                      <given-names>O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Insulin resistance: a marker of surgical stress</article-title>
                  <source>Curr Opin Clin Nutr Metab Care</source>
                  <volume>2</volume>
                  <issue>1</issue>
                  <year>1999</year>
                  <fpage>69</fpage>
                  <lpage>78</lpage>
                  <pub-id pub-id-type="pmid">10453333</pub-id>
                </element-citation>
              </ref>
              <ref id="bib3">
                <label>3</label>
                <element-citation publication-type="journal" id="sref3">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Witasp</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Nordfors</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Schalling</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Nygren</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ljungqvist</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Thorell</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Increased expression of inflammatory pathway genes in skeletal muscle during surgery</article-title>
                  <source>Clin Nutr</source>
                  <volume>28</volume>
                  <issue>3</issue>
                  <year>2009</year>
                  <fpage>291</fpage>
                  <lpage>298</lpage>
                  <pub-id pub-id-type="pmid">19346035</pub-id>
                </element-citation>
              </ref>
              <ref id="bib4">
                <label>4</label>
                <element-citation publication-type="journal" id="sref4">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Witasp</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Nordfors</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Schalling</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Nygren</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Ljungqvist</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Thorell</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Expression of inflammatory and insulin signaling genes in adipose tissue in response to elective surgery</article-title>
                  <source>J Clin Endocrinol Metab</source>
                  <volume>95</volume>
                  <issue>7</issue>
                  <year>2010</year>
                  <fpage>3460</fpage>
                  <lpage>3469</lpage>
                  <pub-id pub-id-type="pmid">20444921</pub-id>
                </element-citation>
              </ref>
              <ref id="bib5">
                <label>5</label>
                <element-citation publication-type="journal" id="sref5">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tewari</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Awad</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Macdonald</surname>
                      <given-names>I.A.</given-names>
                    </name>
                    <name>
                      <surname>Lobo</surname>
                      <given-names>D.N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Obesity-related insulin resistance: implications for the surgical patient</article-title>
                  <source>Int J Obes</source>
                  <volume>39</volume>
                  <issue>11</issue>
                  <year>2015</year>
                  <fpage>1575</fpage>
                  <lpage>1588</lpage>
                </element-citation>
              </ref>
              <ref id="bib6">
                <label>6</label>
                <element-citation publication-type="journal" id="sref6">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Alberti</surname>
                      <given-names>K.G.</given-names>
                    </name>
                    <name>
                      <surname>Zimmet</surname>
                      <given-names>P.Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation</article-title>
                  <source>Diabet Med</source>
                  <volume>15</volume>
                  <issue>7</issue>
                  <year>1998</year>
                  <fpage>539</fpage>
                  <lpage>553</lpage>
                  <pub-id pub-id-type="pmid">9686693</pub-id>
                </element-citation>
              </ref>
              <ref id="bib7">
                <label>7</label>
                <element-citation publication-type="journal" id="sref7">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nygren</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Soop</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Thorell</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Efendic</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Nair</surname>
                      <given-names>K.S.</given-names>
                    </name>
                    <name>
                      <surname>Ljungqvist</surname>
                      <given-names>O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Preoperative oral carbohydrate administration reduces postoperative insulin resistance</article-title>
                  <source>Clin Nutr</source>
                  <volume>17</volume>
                  <issue>2</issue>
                  <year>1998</year>
                  <fpage>65</fpage>
                  <lpage>71</lpage>
                  <pub-id pub-id-type="pmid">10205319</pub-id>
                </element-citation>
              </ref>
              <ref id="bib8">
                <label>8</label>
                <element-citation publication-type="journal" id="sref8">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nygren</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Soop</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Thorell</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Sree Nair</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Ljungqvist</surname>
                      <given-names>O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Preoperative oral carbohydrates and postoperative insulin resistance</article-title>
                  <source>Clin Nutr</source>
                  <volume>18</volume>
                  <issue>2</issue>
                  <year>1999</year>
                  <fpage>117</fpage>
                  <lpage>120</lpage>
                  <pub-id pub-id-type="pmid">10459075</pub-id>
                </element-citation>
              </ref>
              <ref id="bib9">
                <label>9</label>
                <element-citation publication-type="journal" id="sref9">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ljungqvist</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Thorell</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Gutniak</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Häggmark</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Efendic</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Glucose infusion instead of preoperative fasting reduces postoperative insulin resistance</article-title>
                  <source>J Am Coll Surg</source>
                  <volume>178</volume>
                  <issue>4</issue>
                  <year>1994</year>
                  <fpage>329</fpage>
                  <lpage>336</lpage>
                  <pub-id pub-id-type="pmid">8149032</pub-id>
                </element-citation>
              </ref>
              <ref id="bib10">
                <label>10</label>
                <element-citation publication-type="journal" id="sref10">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smith</surname>
                      <given-names>M.D.</given-names>
                    </name>
                    <name>
                      <surname>McCall</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Plank</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Herbison</surname>
                      <given-names>G.P.</given-names>
                    </name>
                    <name>
                      <surname>Soop</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Nygren</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Preoperative carbohydrate treatment for enhancing recovery after elective surgery</article-title>
                  <source>Cochrane Database Syst Rev</source>
                  <issue>8</issue>
                  <year>2014</year>
                  <fpage>CD009161</fpage>
                  <pub-id pub-id-type="pmid">25121931</pub-id>
                </element-citation>
              </ref>
              <ref id="bib11">
                <label>11</label>
                <element-citation publication-type="journal" id="sref11">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Awad</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Varadhan</surname>
                      <given-names>K.K.</given-names>
                    </name>
                    <name>
                      <surname>Ljungqvist</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Lobo</surname>
                      <given-names>D.N.</given-names>
                    </name>
                  </person-group>
                  <article-title>A meta-analysis of randomised controlled trials on preoperative oral carbohydrate treatment in elective surgery</article-title>
                  <source>Clin Nutr</source>
                  <volume>32</volume>
                  <issue>1</issue>
                  <year>2013</year>
                  <fpage>34</fpage>
                  <lpage>44</lpage>
                  <pub-id pub-id-type="pmid">23200124</pub-id>
                </element-citation>
              </ref>
              <ref id="bib12">
                <label>12</label>
                <element-citation publication-type="journal" id="sref12">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Amer</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>M.D.</given-names>
                    </name>
                    <name>
                      <surname>Herbison</surname>
                      <given-names>G.P.</given-names>
                    </name>
                    <name>
                      <surname>Plank</surname>
                      <given-names>L.D.</given-names>
                    </name>
                    <name>
                      <surname>McCall</surname>
                      <given-names>J.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Network meta-analysis of the effect of preoperative carbohydrate loading on recovery after elective surgery</article-title>
                  <source>Br J Surg</source>
                  <volume>104</volume>
                  <issue>3</issue>
                  <year>2017</year>
                  <fpage>187</fpage>
                  <lpage>197</lpage>
                  <pub-id pub-id-type="pmid">28000931</pub-id>
                </element-citation>
              </ref>
              <ref id="bib13">
                <label>13</label>
                <element-citation publication-type="journal" id="sref13">
                  <person-group person-group-type="author">
                    <name>
                      <surname>DeFronzo</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Tobin</surname>
                      <given-names>J.D.</given-names>
                    </name>
                    <name>
                      <surname>Andres</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Glucose clamp technique: a method for quantifying insulin secretion and resistance</article-title>
                  <source>Am J Physiol</source>
                  <volume>237</volume>
                  <issue>3</issue>
                  <year>1979</year>
                  <fpage>E214</fpage>
                  <lpage>E223</lpage>
                  <pub-id pub-id-type="pmid">382871</pub-id>
                </element-citation>
              </ref>
              <ref id="bib14">
                <label>14</label>
                <element-citation publication-type="journal" id="sref14">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dindo</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Demartines</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Clavien</surname>
                      <given-names>P.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey</article-title>
                  <source>Ann Surg</source>
                  <volume>240</volume>
                  <issue>2</issue>
                  <year>2004</year>
                  <fpage>205</fpage>
                  <lpage>213</lpage>
                  <pub-id pub-id-type="pmid">15273542</pub-id>
                </element-citation>
              </ref>
              <ref id="bib15">
                <label>15</label>
                <element-citation publication-type="journal" id="sref15">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Doyle</surname>
                      <given-names>S.L.</given-names>
                    </name>
                    <name>
                      <surname>Lysaght</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Reynolds</surname>
                      <given-names>J.V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Obesity and post-operative complications in patients undergoing non-bariatric surgery</article-title>
                  <source>Obes Rev</source>
                  <volume>11</volume>
                  <issue>12</issue>
                  <year>2010</year>
                  <fpage>875</fpage>
                  <lpage>886</lpage>
                  <pub-id pub-id-type="pmid">20025695</pub-id>
                </element-citation>
              </ref>
              <ref id="bib16">
                <label>16</label>
                <element-citation publication-type="journal" id="sref16">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gjessing</surname>
                      <given-names>P.F.</given-names>
                    </name>
                    <name>
                      <surname>Constantin-Teodosiu</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Hagve</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Lobo</surname>
                      <given-names>D.N.</given-names>
                    </name>
                    <name>
                      <surname>Revhaug</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Irtun</surname>
                      <given-names>Ø.</given-names>
                    </name>
                  </person-group>
                  <article-title>Preoperative carbohydrate supplementation attenuates post-surgery insulin resistance via reduced inflammatory inhibition of the insulin-mediated restraint on muscle pyruvate dehydrogenase kinase 4 expression</article-title>
                  <source>Clin Nutr</source>
                  <volume>34</volume>
                  <issue>6</issue>
                  <year>2015</year>
                  <fpage>1177</fpage>
                  <lpage>1183</lpage>
                  <pub-id pub-id-type="pmid">25534879</pub-id>
                </element-citation>
              </ref>
              <ref id="bib17">
                <label>17</label>
                <element-citation publication-type="journal" id="sref17">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gjessing</surname>
                      <given-names>P.F.</given-names>
                    </name>
                    <name>
                      <surname>Hagve</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Fuskevåg</surname>
                      <given-names>O.M.</given-names>
                    </name>
                    <name>
                      <surname>Larsen</surname>
                      <given-names>T.S.</given-names>
                    </name>
                    <name>
                      <surname>Irtun</surname>
                      <given-names>Ø.</given-names>
                    </name>
                  </person-group>
                  <article-title>Single-dose carbohydrate treatment in the immediate preoperative phase diminishes development of postoperative peripheral insulin resistance</article-title>
                  <source>Clin Nutr</source>
                  <volume>34</volume>
                  <issue>1</issue>
                  <year>2015</year>
                  <fpage>156</fpage>
                  <lpage>164</lpage>
                  <pub-id pub-id-type="pmid">24656290</pub-id>
                </element-citation>
              </ref>
              <ref id="bib18">
                <label>18</label>
                <element-citation publication-type="journal" id="sref18">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Varadhan</surname>
                      <given-names>K.K.</given-names>
                    </name>
                    <name>
                      <surname>Constantin-Teodosiu</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Constantin</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Greenhaff</surname>
                      <given-names>P.L.</given-names>
                    </name>
                    <name>
                      <surname>Lobo</surname>
                      <given-names>D.N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Inflammation-mediated muscle metabolic dysregulation local and remote to the site of major abdominal surgery</article-title>
                  <source>Clin Nutr</source>
                  <year>2017</year>
                  <comment>[Epub ahead of print]</comment>
                </element-citation>
              </ref>
              <ref id="bib19">
                <label>19</label>
                <element-citation publication-type="journal" id="sref19">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Høgevold</surname>
                      <given-names>H.E.</given-names>
                    </name>
                    <name>
                      <surname>Lyberg</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Kähler</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Haug</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Reikerås</surname>
                      <given-names>O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Changes in IL-1 beta, TNF-alpha, and IL-6 after total hip replacement surgery in general or regional anaesthesia</article-title>
                  <source>Cytokine</source>
                  <volume>12</volume>
                  <issue>7</issue>
                  <year>2000</year>
                  <fpage>1156</fpage>
                  <lpage>1159</lpage>
                  <pub-id pub-id-type="pmid">10880268</pub-id>
                </element-citation>
              </ref>
              <ref id="bib20">
                <label>20</label>
                <element-citation publication-type="journal" id="sref20">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Esteve</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Ricart</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Fernandez-Real</surname>
                      <given-names>J.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Dyslipidemia and inflammation: an evolutionary conserved mechanism</article-title>
                  <source>Clin Nutr</source>
                  <volume>24</volume>
                  <issue>1</issue>
                  <year>2005</year>
                  <fpage>16</fpage>
                  <lpage>31</lpage>
                  <pub-id pub-id-type="pmid">15681098</pub-id>
                </element-citation>
              </ref>
              <ref id="bib21">
                <label>21</label>
                <element-citation publication-type="journal" id="sref21">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shulman</surname>
                      <given-names>A.I.</given-names>
                    </name>
                    <name>
                      <surname>Mangelsdorf</surname>
                      <given-names>D.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Retinoid x receptor heterodimers in the metabolic syndrome</article-title>
                  <source>N Engl J Med</source>
                  <volume>353</volume>
                  <issue>6</issue>
                  <year>2005</year>
                  <fpage>604</fpage>
                  <lpage>615</lpage>
                  <pub-id pub-id-type="pmid">16093469</pub-id>
                </element-citation>
              </ref>
              <ref id="bib22">
                <label>22</label>
                <element-citation publication-type="journal" id="sref22">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Guerre-Millo</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Gervois</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Raspe</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Madsen</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Poulain</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Derudas</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity</article-title>
                  <source>J Biol Chem</source>
                  <volume>275</volume>
                  <issue>22</issue>
                  <year>2000</year>
                  <fpage>16638</fpage>
                  <lpage>16642</lpage>
                  <pub-id pub-id-type="pmid">10828060</pub-id>
                </element-citation>
              </ref>
              <ref id="bib23">
                <label>23</label>
                <element-citation publication-type="journal" id="sref23">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reddy</surname>
                      <given-names>J.K.</given-names>
                    </name>
                    <name>
                      <surname>Hashimoto</surname>
                      <given-names>T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system</article-title>
                  <source>Annu Rev Nutr</source>
                  <volume>21</volume>
                  <year>2001</year>
                  <fpage>193</fpage>
                  <lpage>230</lpage>
                  <pub-id pub-id-type="pmid">11375435</pub-id>
                </element-citation>
              </ref>
              <ref id="bib24">
                <label>24</label>
                <element-citation publication-type="journal" id="sref24">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chou</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <name>
                      <surname>Haluzik</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Gregory</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Dietz</surname>
                      <given-names>K.R.</given-names>
                    </name>
                    <name>
                      <surname>Vinson</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Gavrilova</surname>
                      <given-names>O.</given-names>
                    </name>
                  </person-group>
                  <article-title>WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice</article-title>
                  <source>J Biol Chem</source>
                  <volume>277</volume>
                  <issue>27</issue>
                  <year>2002</year>
                  <fpage>24484</fpage>
                  <lpage>24489</lpage>
                  <pub-id pub-id-type="pmid">11994294</pub-id>
                </element-citation>
              </ref>
              <ref id="bib25">
                <label>25</label>
                <element-citation publication-type="journal" id="sref25">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Haluzik</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Asghar</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Yau</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Joseph</surname>
                      <given-names>J.W.</given-names>
                    </name>
                    <name>
                      <surname>Fernandez</surname>
                      <given-names>A.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis</article-title>
                  <source>Diabetes</source>
                  <volume>52</volume>
                  <issue>7</issue>
                  <year>2003</year>
                  <fpage>1770</fpage>
                  <lpage>1778</lpage>
                  <pub-id pub-id-type="pmid">12829645</pub-id>
                </element-citation>
              </ref>
              <ref id="bib26">
                <label>26</label>
                <element-citation publication-type="journal" id="sref26">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lecker</surname>
                      <given-names>S.H.</given-names>
                    </name>
                    <name>
                      <surname>Jagoe</surname>
                      <given-names>R.T.</given-names>
                    </name>
                    <name>
                      <surname>Gilbert</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Gomes</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Baracos</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Bailey</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression</article-title>
                  <source>FASEB J</source>
                  <volume>18</volume>
                  <issue>1</issue>
                  <year>2004</year>
                  <fpage>39</fpage>
                  <lpage>51</lpage>
                  <pub-id pub-id-type="pmid">14718385</pub-id>
                </element-citation>
              </ref>
              <ref id="bib27">
                <label>27</label>
                <element-citation publication-type="journal" id="sref27">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Randle</surname>
                      <given-names>P.J.</given-names>
                    </name>
                    <name>
                      <surname>Garland</surname>
                      <given-names>P.B.</given-names>
                    </name>
                    <name>
                      <surname>Hales</surname>
                      <given-names>C.N.</given-names>
                    </name>
                    <name>
                      <surname>Newsholme</surname>
                      <given-names>E.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus</article-title>
                  <source>Lancet</source>
                  <volume>1</volume>
                  <issue>7285</issue>
                  <year>1963</year>
                  <fpage>785</fpage>
                  <lpage>789</lpage>
                  <pub-id pub-id-type="pmid">13990765</pub-id>
                </element-citation>
              </ref>
              <ref id="bib28">
                <label>28</label>
                <element-citation publication-type="journal" id="sref28">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Glass</surname>
                      <given-names>D.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Signalling pathways that mediate skeletal muscle hypertrophy and atrophy</article-title>
                  <source>Nat Cell Biol</source>
                  <volume>5</volume>
                  <issue>2</issue>
                  <year>2003</year>
                  <fpage>87</fpage>
                  <lpage>90</lpage>
                  <pub-id pub-id-type="pmid">12563267</pub-id>
                </element-citation>
              </ref>
              <ref id="bib29">
                <label>29</label>
                <element-citation publication-type="journal" id="sref29">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Larsen</surname>
                      <given-names>A.E.</given-names>
                    </name>
                    <name>
                      <surname>Tunstall</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>Carey</surname>
                      <given-names>K.A.</given-names>
                    </name>
                    <name>
                      <surname>Nicholas</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Kambadur</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Crowe</surname>
                      <given-names>T.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Actions of short-term fasting on human skeletal muscle myogenic and atrogenic gene expression</article-title>
                  <source>Ann Nutr Metab</source>
                  <volume>50</volume>
                  <issue>5</issue>
                  <year>2006</year>
                  <fpage>476</fpage>
                  <lpage>481</lpage>
                  <pub-id pub-id-type="pmid">16931880</pub-id>
                </element-citation>
              </ref>
              <ref id="bib30">
                <label>30</label>
                <element-citation publication-type="journal" id="sref30">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stitt</surname>
                      <given-names>T.N.</given-names>
                    </name>
                    <name>
                      <surname>Drujan</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Clarke</surname>
                      <given-names>B.A.</given-names>
                    </name>
                    <name>
                      <surname>Panaro</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Timofeyva</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Kline</surname>
                      <given-names>W.O.</given-names>
                    </name>
                  </person-group>
                  <article-title>The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors</article-title>
                  <source>Mol Cell</source>
                  <volume>14</volume>
                  <issue>3</issue>
                  <year>2004</year>
                  <fpage>395</fpage>
                  <lpage>403</lpage>
                  <pub-id pub-id-type="pmid">15125842</pub-id>
                </element-citation>
              </ref>
              <ref id="bib31">
                <label>31</label>
                <element-citation publication-type="journal" id="sref31">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hirner</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Krohne</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Schuster</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Hoffmann</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Witt</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Erber</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>MuRF1-dependent regulation of systemic carbohydrate metabolism as revealed from transgenic mouse studies</article-title>
                  <source>J Mol Biol</source>
                  <volume>379</volume>
                  <issue>4</issue>
                  <year>2008</year>
                  <fpage>666</fpage>
                  <lpage>677</lpage>
                  <pub-id pub-id-type="pmid">18468620</pub-id>
                </element-citation>
              </ref>
              <ref id="bib32">
                <label>32</label>
                <element-citation publication-type="journal" id="sref32">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cohen</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Nathan</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Goldberg</surname>
                      <given-names>A.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Muscle wasting in disease: molecular mechanisms and promising therapies</article-title>
                  <source>Nat Rev Drug Discov</source>
                  <volume>14</volume>
                  <issue>1</issue>
                  <year>2015</year>
                  <fpage>58</fpage>
                  <lpage>74</lpage>
                  <pub-id pub-id-type="pmid">25549588</pub-id>
                </element-citation>
              </ref>
              <ref id="bib33">
                <label>33</label>
                <element-citation publication-type="journal" id="sref33">
                  <person-group person-group-type="author">
                    <name>
                      <surname>González-Roldán</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Ferat-Osorio</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Aduna-Vicente</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Wong-Baeza</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Esquivel-Callejas</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Astudillo-de la Vega</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Expression of triggering receptor on myeloid cell 1 and histocompatibility complex molecules in sepsis and major abdominal surgery</article-title>
                  <source>World J Gastroenterol</source>
                  <volume>11</volume>
                  <issue>47</issue>
                  <year>2005</year>
                  <fpage>7473</fpage>
                  <lpage>7479</lpage>
                  <pub-id pub-id-type="pmid">16437719</pub-id>
                </element-citation>
              </ref>
              <ref id="bib34">
                <label>34</label>
                <element-citation publication-type="journal" id="sref34">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>D.Y.</given-names>
                    </name>
                    <name>
                      <surname>Qin</surname>
                      <given-names>R.Y.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>Z.R.</given-names>
                    </name>
                    <name>
                      <surname>Gupta</surname>
                      <given-names>M.K.</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>Q.</given-names>
                    </name>
                  </person-group>
                  <article-title>Expression of TREM-1 mRNA in acute pancreatitis</article-title>
                  <source>World J Gastroenterol</source>
                  <volume>10</volume>
                  <issue>18</issue>
                  <year>2004</year>
                  <fpage>2744</fpage>
                  <lpage>2746</lpage>
                  <pub-id pub-id-type="pmid">15309732</pub-id>
                </element-citation>
              </ref>
              <ref id="bib35">
                <label>35</label>
                <element-citation publication-type="journal" id="sref35">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gustafsson</surname>
                      <given-names>U.O.</given-names>
                    </name>
                    <name>
                      <surname>Scott</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Schwenk</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Demartines</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Roulin</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Francis</surname>
                      <given-names>N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Enhanced Recovery After Surgery (ERAS) Society, for perioperative care; European Society for Clinical Nutrition and Metabolism (ESPEN); International Association for Surgical Metabolism and Nutrition (IASMEN). Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS<sup>®</sup>) Society recommendations</article-title>
                  <source>World J Surg</source>
                  <volume>37</volume>
                  <issue>2</issue>
                  <year>2013</year>
                  <fpage>259</fpage>
                  <lpage>284</lpage>
                  <pub-id pub-id-type="pmid">23052794</pub-id>
                </element-citation>
              </ref>
            </ref-list>
            <sec id="appsec1" sec-type="supplementary-material">
              <label>Appendix A</label>
              <title>Supplementary data</title>
              <p id="p0245">The following is the supplementary data related to this article:<supplementary-material content-type="local-data" id="mmc1"><caption><title>mmc1</title></caption><media xlink:href="mmc1.zip"/></supplementary-material></p>
            </sec>
            <fn-group>
              <fn id="d31e554">
                <label>☆</label>
                <p id="ntpara0010">This paper was presented to the International Association of Surgical Nutrition and Metabolism (IASMEN) at the 47th World Congress of Surgery, Basel, September 2017 and Nilanjana Tewari was awarded the Graham Hill Prize for the Best Presentation.</p>
              </fn>
              <fn id="appsec2" fn-type="supplementary-material">
                <label>Appendix A</label>
                <p id="p0250">Supplementary data related to this article can be found at <ext-link ext-link-type="doi" xlink:href="10.1016/j.clnu.2018.01.032" id="intref0015">https://doi.org/10.1016/j.clnu.2018.01.032</ext-link>.</p>
              </fn>
            </fn-group>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
